Case number 2016-1518
Los Angeles Biomedical v. Eli Lilly and Company > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | LOS ANGELES BIOMEDICAL v. ELI LILLY AND COMPANY [OPINION] [precedential] (0) |
| Apr 13, 2017 | 45 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by Clerk of Court. [424027] [FMS] [Entered: 04/13/2017 05:13 PM] (0) |
| Feb 28, 2017 | 44 | OPINION and JUDGMENT filed. The judgment or decision is: Vacated and Remanded. (Precedential Opinion). (For the Court: Newman,Circuit Judge; Bryson,Circuit Judge and Moore,Circuit Judge). Opinion concurring in part, dissenting from the judgment filed by Circuit Judge Newman. [411060] [SJ] [Entered: 02/28/2017 09:13 AM] (0) |
| Nov 7, 2016 | 43 | Submitted after ORAL ARGUMENT by Ewa M. Davison for Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and Mark J. Feldstein for Eli Lilly and Company. Panel: Judge: Newman , Judge: Bryson , Judge: Moore. [380711] [JAB] [Entered: 11/07/2016 10:34 AM] (0) |
| Oct 27, 2016 | 42 | ORDER filed granting motion to file Entry of Appearance of new counsel [40] filed by Appellee Eli Lilly and Company. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [377972] [SJ] [Entered: 10/27/2016 09:37 AM] (0) |
| Oct 19, 2016 | 40 | MOTION of Appellee Eli Lilly and Company to file Entry of Appearance of Yieyie Yang. Response/Opposition is due 11/03/2016 [Consent: unopposed]. Service: 10/19/2016 by email. [375652] [Mark Feldstein] [Entered: 10/19/2016 09:02 AM] (0) |
| Oct 19, 2016 | 41 | Entry of appearance for Yieyie Yang as of counsel for Appellee Eli Lilly and Company. Service: 10/19/2016 by email. [375653] [Mark Feldstein] [Entered: 10/19/2016 09:03 AM] (0) |
| Oct 17, 2016 | 38 | Response to oral argument order from the Appellee Eli Lilly and Company. designating Mark J. Feldstein as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [374761] [Mark Feldstein] [Entered: 10/17/2016 11:34 AM] (0) |
| Oct 17, 2016 | 39 | Response to oral argument order from the Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. designating Ewa M. Davison as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [374777] [Ewa Davison] [Entered: 10/17/2016 11:44 AM] (0) |
| Sep 21, 2016 | 37 | NOTICE OF CALENDARING. Panel: 1611N. Case scheduled Nov 07, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 10/17/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [368172] THIS NOTICE APPLIES TO CASE(S): [16-1249, 16-1518, 16-1547, 16-1711] [JAB] [Entered: 09/21/2016 02:00 PM] (0) |
| Jun 29, 2016 | 36 | Notice from Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center regarding conflicts with oral argument (August 1-5, 2016; September 6-9, 2016). Service: 06/29/2016 by email. [347555] [David Tellekson] [Entered: 06/29/2016 05:47 PM] (0) |
| Jun 28, 2016 | 35 | 6 paper copies of the Joint Appendix (Vol. I-IV) [33] received from Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. [347133] [KW] [Entered: 06/28/2016 03:53 PM] (0) |
| Jun 24, 2016 | 34 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice of Conflict with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/01/2016. [346365] [SJ] [Entered: 06/24/2016 01:32 PM] (0) |
| Jun 23, 2016 | 33 | APPENDIX FILED for Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center [32]. Number of Pages: 1578. Service: 06/23/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/29/2016. [346364] [SJ] [Entered: 06/24/2016 01:32 PM] (1583) |
| Jun 23, 2016 | 32 | TENDERED from Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Title: JOINT APPENDIX. Service: 06/23/2016 by email. [346034] [David Tellekson] [Entered: 06/23/2016 12:38 PM] (1583) |
| Jun 20, 2016 | 31 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 06/20/2016 by email. [344948] [Ewa Davison] [Entered: 06/20/2016 12:53 PM] (4) |
| Jun 17, 2016 | 30 | 6 paper copies of the Reply Brief [29] received from Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. [344678] [KW] [Entered: 06/17/2016 02:58 PM] (0) |
| Jun 13, 2016 | 29 | REPLY BRIEF FILED for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center [28]. Number of Pages: 31. Service: 06/13/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/20/2016. Appendix is due 06/23/2016. [343362] [SJ] [Entered: 06/14/2016 12:58 PM] (41) |
| Jun 13, 2016 | 28 | TENDERED from Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Title: REPLY BRIEF. Service: 06/13/2016 by email. [343137] [David Tellekson] [Entered: 06/13/2016 06:06 PM] (41) |
| May 24, 2016 | 27 | 6 paper copies of the Response Brief [26] received from Appellee Eli Lilly and Company. [338647] [MJL] [Entered: 05/26/2016 10:22 AM] (0) |
| May 19, 2016 | 26 | BRIEF FILED for Appellee Eli Lilly and Company [25]. Number of Pages: 61. Service: 05/19/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/25/2016. [337234] [SJ] [Entered: 05/20/2016 03:25 PM] (74) |
| May 19, 2016 | 25 | TENDERED from Appellee Eli Lilly and Company. Title: RESPONSE BRIEF. Service: 05/19/2016 by email. [336931] [Mark Feldstein] [Entered: 05/19/2016 04:23 PM] (74) |
| May 18, 2016 | 24 | Entry of appearance for Mark J. Stewart as of counsel for Appellee Eli Lilly and Company. Service: 05/18/2016 by email. [336492] [Mark Feldstein] [Entered: 05/18/2016 02:15 PM] (2) |
| Apr 21, 2016 | 23 | ORDER filed. The motion [22] is granted. The appellee's response brief is due May 19, 2016, and the appellant's reply brief is due June 13, 2016. Service: 04/21/2016 by clerk. [328413] [LMS] [Entered: 04/21/2016 12:00 PM] (2) |
| Apr 15, 2016 | 22 | MOTION of Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center to extend the time to 05/19/2016 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 04/28/2016, to extend the time to 06/13/2016 to file the reply brief. Response/Opposition is due 04/28/2016 [Consent: unopposed]. Service: 04/15/2016 by email. [326921] [David Tellekson] [Entered: 04/15/2016 05:58 PM] (7) |
| Apr 1, 2016 | 21 | 6 paper copies of the Opening Brief [20] received from Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. [324158] [LAJ] [Entered: 04/05/2016 03:36 PM] (0) |
| Mar 28, 2016 | 19 | TENDERED from Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Title: OPENING BRIEF. Service: 03/28/2016 by email. [322251] [David Tellekson] [Entered: 03/28/2016 05:28 PM] (169) |
| Mar 28, 2016 | 20 | BRIEF FILED for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center [19]. Number of Pages: 62. Service: 03/28/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/04/2016. Appellee Eli Lilly and Company brief is due 05/12/2016. [322331] [JCA] [Entered: 03/29/2016 09:26 AM] (169) |
| Feb 12, 2016 | 17 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [7], ERROR: Attorney Joshua L. Goldberg for Appellee Eli Lily and Company is not a registered CM/ECF filer. CORRECTION: In accordance with ECF-2, Joshua L. Golberg must register as a CM/ECF filer. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [310594] [MJL] [Entered: 02/12/2016 08:36 AM] (0) |
| Feb 12, 2016 | 18 | NOTICE OF DEFICIENCY: The attorney entry of appearance for Dan L. Wood (Document No. [9]) and attorney entry of appearance for Mark J. Stewart (Document No. [8]) filed by Appellee Eli Lilly and Company in 16-1518 contain addresses that do not match their respective user accounts, and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [310598] [MJL] [Entered: 02/12/2016 08:48 AM] (0) |
| Feb 11, 2016 | 14 | Entry of appearance for Ewa M. Davison as of counsel for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 02/11/2016 by email. [310531] [Ewa Davison] [Entered: 02/11/2016 06:04 PM] (2) |
| Feb 11, 2016 | 16 | Entry of appearance for Elizabeth B. Hagan as of counsel for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 02/11/2016 by email. [310533] [Elizabeth Hagan] [Entered: 02/11/2016 06:08 PM] (2) |
| Feb 11, 2016 | 15 | Entry of appearance for Amy Hayden as of counsel for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 02/11/2016 by email. [310532] [Amy Hayden] [Entered: 02/11/2016 06:06 PM] (2) |
| Feb 11, 2016 | 13 | Entry of appearance for Virginia K. DeMarchi as of counsel for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 02/11/2016 by email. [310530] [Virginia DeMarchi] [Entered: 02/11/2016 06:02 PM] (2) |
| Feb 11, 2016 | 12 | Entry of appearance for David K. Tellekson as principal counsel for Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 02/11/2016 by email. [310529] [David Tellekson] [Entered: 02/11/2016 05:59 PM] (2) |
| Feb 11, 2016 | 11 | Certificate of Interest for the Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 02/11/2016 by email. [310528] [David Tellekson] [Entered: 02/11/2016 05:58 PM] (2) |
| Feb 11, 2016 | 10 | Docketing Statement for the Appellant Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Service: 02/11/2016 by email. [310527] [David Tellekson] [Entered: 02/11/2016 05:57 PM] (3) |
| Feb 11, 2016 | 9 | Entry of appearance for Dan L. Wood as of counsel for Appellee Eli Lilly and Company. Service: 02/11/2016 by email. [310371] [Mark Feldstein] [Entered: 02/11/2016 12:46 PM] (0) |
| Feb 11, 2016 | 8 | Entry of appearance for Mark J. Stewart as of counsel for Appellee Eli Lilly and Company. Service: 02/11/2016 by email. [310368] [Mark Feldstein] [Entered: 02/11/2016 12:46 PM] (0) |
| Feb 11, 2016 | 7 | Entry of appearance for Joshua L. Goldberg as of counsel for Appellee Eli Lilly and Company. Service: 02/11/2016 by email. [310367] [Mark Feldstein] [Entered: 02/11/2016 12:45 PM] (2) |
| Feb 11, 2016 | 6 | Entry of appearance for Charles E. Lipsey as of counsel for Appellee Eli Lilly and Company. Service: 02/11/2016 by email. [310366] [Mark Feldstein] [Entered: 02/11/2016 12:44 PM] (2) |
| Feb 11, 2016 | 5 | Docketing Statement for the Appellee Eli Lilly and Company. Service: 02/11/2016 by email. [310365] [Mark Feldstein] [Entered: 02/11/2016 12:43 PM] (3) |
| Feb 11, 2016 | 4 | Certificate of Interest for the Appellee Eli Lilly and Company. Service: 02/11/2016 by email. [310363] [Mark Feldstein] [Entered: 02/11/2016 12:42 PM] (3) |
| Feb 11, 2016 | 3 | Entry of appearance for Mark J. Feldstein as principal counsel for Appellee Eli Lilly and Company. Service: 02/11/2016 by email. [310362] [Mark Feldstein] [Entered: 02/11/2016 12:41 PM] (2) |
| Feb 4, 2016 | 2 | Note to file: 16-1547 (COMPANION started 02/04/2016) with 16-1518. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [308426] [16-1547, 16-1518] [JW] [Entered: 02/04/2016 09:58 AM] (0) |
| Jan 28, 2016 | 1 | Appeal docketed. Date received: 12/18/2015. [306446] Entry of Appearance due 02/11/2016. Certificate of Interest is due on 02/11/2016. Docketing Statement due 02/11/2016. Appellant/Petitioner's brief is due 03/28/2016. [JW] [Entered: 01/28/2016 09:19 AM] (82) |
